Literature DB >> 27369469

Ingestion of the epoxide hydrolase inhibitor AUDA modulates immune responses of the mosquito, Culex quinquefasciatus during blood feeding.

Jiawen Xu1, Christophe Morisseau1, Jun Yang1, Kin Sing Stephen Lee1, Shizuo G Kamita1, Bruce D Hammock2.   

Abstract

Epoxide hydrolases (EHs) are enzymes that play roles in metabolizing xenobiotic epoxides from the environment, and in regulating lipid signaling molecules, such as juvenile hormones in insects and epoxy fatty acids in mammals. In this study we fed mosquitoes with an epoxide hydrolase inhibitor AUDA during artificial blood feeding, and we found the inhibitor increased the concentration of epoxy fatty acids in the midgut of female mosquitoes. We also observed ingestion of AUDA triggered early expression of defensin A, cecropin A and cecropin B2 at 6 h after blood feeding. The expression of cecropin B1 and gambicin were not changed more than two fold compared to controls. The changes in gene expression were transient possibly because more than 99% of the inhibitor was metabolized or excreted at 42 h after being ingested. The ingestion of AUDA also affected the growth of bacteria colonizing in the midgut, but did not affect mosquito longevity, fecundity and fertility in our laboratory conditions. When spiked into the blood, EpOMEs and DiHOMEs were as effective as the inhibitor AUDA in reducing the bacterial load in the midgut, while EETs rescued the effects of AUDA. Our data suggest that epoxy fatty acids from host blood are immune response regulators metabolized by epoxide hydrolases in the midgut of female mosquitoes, inhibition of which causes transient changes in immune responses, and affects growth of microbes in the midgut.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Blood feeding; Epoxide hydrolase; Epoxy fatty acids; Immune response; Mosquito

Mesh:

Substances:

Year:  2016        PMID: 27369469      PMCID: PMC5010450          DOI: 10.1016/j.ibmb.2016.06.011

Source DB:  PubMed          Journal:  Insect Biochem Mol Biol        ISSN: 0965-1748            Impact factor:   4.714


  45 in total

1.  Leukotoxin and its diol induce neutrophil chemotaxis through signal transduction different from that of fMLP.

Authors:  Y Totani; Y Saito; T Ishizaki; F Sasaki; S Ameshima; I Miyamori
Journal:  Eur Respir J       Date:  2000-01       Impact factor: 16.671

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.

Authors:  Z Yu; F Xu; L M Huse; C Morisseau; A J Draper; J W Newman; C Parker; L Graham; M M Engler; B D Hammock; D C Zeldin; D L Kroetz
Journal:  Circ Res       Date:  2000-11-24       Impact factor: 17.367

4.  Existence of leukotoxin 9,10-epoxy-12-octadecenoate in lung lavages from rats breathing pure oxygen and from patients with the adult respiratory distress syndrome.

Authors:  T Ozawa; S Sugiyama; M Hayakawa; T Satake; F Taki; M Iwata; K Taki
Journal:  Am Rev Respir Dis       Date:  1988-03

Review 5.  Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

Authors:  John D Imig
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

6.  Nitric oxide is an essential component of the hemocyte-mediated mosquito immune response against bacteria.

Authors:  Julián F Hillyer; Tania Y Estévez-Lao
Journal:  Dev Comp Immunol       Date:  2009-09-11       Impact factor: 3.636

7.  Involvement of CYP 2C9 in mediating the proinflammatory effects of linoleic acid in vascular endothelial cells.

Authors:  Saraswathi Viswanathan; Bruce D Hammock; John W Newman; Purushothaman Meerarani; Michal Toborek; Bernhard Hennig
Journal:  J Am Coll Nutr       Date:  2003-12       Impact factor: 3.169

8.  Activation of Akt signaling reduces the prevalence and intensity of malaria parasite infection and lifespan in Anopheles stephensi mosquitoes.

Authors:  Vanessa Corby-Harris; Anna Drexler; Laurel Watkins de Jong; Yevgeniya Antonova; Nazzy Pakpour; Rolf Ziegler; Frank Ramberg; Edwin E Lewis; Jessica M Brown; Shirley Luckhart; Michael A Riehle
Journal:  PLoS Pathog       Date:  2010-07-15       Impact factor: 6.823

9.  Transcriptome analysis of Aedes aegypti transgenic mosquitoes with altered immunity.

Authors:  Zhen Zou; Jayme Souza-Neto; Zhiyong Xi; Vladimir Kokoza; Sang Woon Shin; George Dimopoulos; Alexander Raikhel
Journal:  PLoS Pathog       Date:  2011-11-17       Impact factor: 6.823

10.  Caspar controls resistance to Plasmodium falciparum in diverse anopheline species.

Authors:  Lindsey S Garver; Yuemei Dong; George Dimopoulos
Journal:  PLoS Pathog       Date:  2009-03-13       Impact factor: 6.823

View more
  5 in total

1.  Exported Epoxide Hydrolases Modulate Erythrocyte Vasoactive Lipids during Plasmodium falciparum Infection.

Authors:  Natalie J Spillman; Varun K Dalmia; Daniel E Goldberg
Journal:  mBio       Date:  2016-10-18       Impact factor: 7.867

Review 2.  Eicosanoid Signaling in Insect Immunology: New Genes and Unresolved Issues.

Authors:  Yonggyun Kim; David Stanley
Journal:  Genes (Basel)       Date:  2021-02-01       Impact factor: 4.096

3.  Host Immunosuppression Induced by Steinernema feltiae, an Entomopathogenic Nematode, through Inhibition of Eicosanoid Biosynthesis.

Authors:  Miltan Chandra Roy; Dongwoon Lee; Yonggyun Kim
Journal:  Insects       Date:  2019-12-31       Impact factor: 2.769

4.  Inhibitors of Eicosanoid Biosynthesis Reveal that Multiple Lipid Signaling Pathways Influence Malaria Parasite Survival in Anopheles gambiae.

Authors:  Hyeogsun Kwon; Ryan C Smith
Journal:  Insects       Date:  2019-09-20       Impact factor: 2.769

5.  EpOMEs act as immune suppressors in a lepidopteran insect, Spodoptera exigua.

Authors:  Mohammad Vatanparast; Shabbir Ahmed; Dong-Hee Lee; Sung Hee Hwang; Bruce Hammock; Yonggyun Kim
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.